您的位置: 首页 > 农业专利 > 详情页

COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING A DISEASE, DISORDER, SYNDROME OR AFFECTION MEDIATED BY NADPH OXIDASE IN AN INDIVIDUAL
专利权人:
GLENMARK PHARMACEUTICALS S.A.
发明人:
ABRAHAM THOMAS,DAISY MANISH SHAH,INDRANIL MUKHOPADHYAY,LAXMIKANT ATMARAM GHARAT,NEELIMA KHAIRATKAR-JOSHI,SACHIN SUNDARLAL CHAUDHARI,SUKEERTHI KUMAR
申请号:
BR112019023109
公开号:
BR112019023109A2
申请日:
2018.05.04
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
the present application relates to substituted heteroaryl and fused heterocyclic compounds useful as nicotinamide oxidase adenine dinucleotide phosphate inhibitors (nadph oxidase inhibitors), processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or compounds compositions in the treatment or prevention of various diseases, conditions and / or disorders mediated by nadph oxidase.o presente pedido se refere a compostos de heteroarila e heterocíclicos fundidos substituídos úteis como inibidores de fosfato dinucleotídico de adenina de nicotinamida oxidase (inibidores de nadph oxidase), processos para sua preparação, composições farmacêuticas que compreendem os compostos, e o uso dos compostos ou das composições no tratamento ou prevenção de várias doenças, afecções e/ou distúrbios mediados por nadph oxidase.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充